Palliative Care in Oncology Market is expected to reach USD 244.1 billion by 2031

Palliative Care in Oncology Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the palliative care in oncology market will expand from USD 165.2 billion in 2026 to USD 244.1 billion in 2031 at a CAGR of 8.1% during the forecast period.

The Palliative Care in Oncology Market is witnessing a strong growth driven by the rising worldwide cancer burden, enhanced awareness about the need to improve patients' quality of life, as well as the increasing adoption of palliative care as a part of the typical oncology treatments. Palliative care aims at easing pain, controlling symptoms caused by therapies, tackling patients' mental and emotional suffering, and offering supportive care throughout the patient's cancer journey. The growing incidence of late-stage cancer cases, in addition to an elderly population that is more vulnerable to cancer, has resulted in a higher need for extensive palliative care services and treatment options.

Request a free sample copy or view the report summary: Palliative Care in Oncology Market Report

Palliative Care in Oncology Market Report Highlights

• It is expected that Pain Management will be the fastest-growing therapy-type segment in the Palliative Care in Oncology market since pain from cancer is very common among patients undergoing treatment, as well as those in the advanced stages of the disease. Alleviating pain is a fundamental goal of palliative care. Therefore, it has resulted in more use of pain relievers, various types of pain management programs, and customized treatment methods.

• In the treatment of moderate-to-severe cancer pain, opioid analgesics will likely experience a great demand due to their high effectiveness. The increase in new cancer cases, the growing need for symptom management, and the continuous introduction of extended-release and abuse-deterrent formulations are some of the major drivers for the growth in this segment.

• Lung cancer is expected to see the fastest growth in the indication segment because of its large disease burden worldwide and the significant symptoms caused by this condition. Those with advanced lung cancer often need palliative treatments aimed at relieving pain, breathlessness, fatigue, and psychological distress. Rising lung cancer cases, along with the broader use of palliative care in cancer treatment, are driving the need for supportive care services and drugs.

• Oral administration is anticipated to be the most rapidly progressing segment in the market due to its multiple advantages, such as convenience, simplicity, and being a suitable option for long-term management of symptoms. The presence of a broad assortment of oral pain-killing, anti-nausea, and other supportive drugs is among the factors most stimulating the oncology palliative care market capacity of this route of administration.

• Online Pharmacies are anticipated to become the fastest-growing channel of distribution primarily because of the enhanced digitalization in healthcare services and the higher consumer inclination towards a convenient way of buying medications. Patients undergoing treatment for cancer and their caregivers are gradually turning to online pharmacies for prescription drugs, care products, and home delivery services.

Palliative Care in Oncology Market Growth Drivers and Restraints

Growth Drivers:

• Rising Global Cancer Burden: Cancer being one of the leading causes of death worldwide, the rise in the number of cancer patients has increased the need for symptom management and supportive care services. Palliative care is crucial in enhancing the quality of life of patients with late-stage and chronic cancers.

• Growing Adoption of Early Palliative Care: More healthcare providers are adding palliative care to cancer treatment to raise patient outcomes. Starting care early can greatly help in pain reduction, treatment side effects, and psychological distress.

Restraints:

• Shortage of Specialized Palliative Care Professionals: Many regions face a shortage of trained palliative care physicians, nurses, and counselors. This limits access to comprehensive supportive care services, particularly in rural and underserved areas.

Palliative Care in Oncology Market Key Development

• Collaboration: In October 2025, Neyyar Medicity, together with Pallium India, launched the Comprehensive Palliative Care Program (CPCP). This event is a meaningful advancement of palliative healthcare into normal medical practice to provide patients and their families with medical treatment as well as complete healthcare that includes treatment of the physical, emotional, and psychosocial needs of the patient.

• Collaboration: In October 2025, CanSupport, India’s leading provider of free palliative care, in partnership with Optum India, unveiled two mobile palliative care clinics (MPCCs) from Optum’s Gurgaon office.

Palliative Care in Oncology Market Segmentation

Knowledge Sourcing Intelligence has segmented the palliative care in oncology market based on drug class, therapy type, indication, route of administration, end user, distribution channel, and region:

Palliative Care in Oncology Market, By Therapy Type

• Pain Management

• Antiemetic Therapy

• Nutritional Support

• Psychological Support

Palliative Care in Oncology Market, By Drug Class

• Opioid Analgesics

• Non-Opioid Analgesics

• 5-HT3 Receptor Antagonists

• NK1 Receptor Antagonists

• Corticosteroids

Palliative Care in Oncology Market, By Indication

• Lung Cancer

• Breast Cancer

• Colorectal Cancer

• Pancreatic Cancer

• Prostate Cancer

Palliative Care in Oncology Market, By Route of Administration

• Oral

• Intravenous

• Transdermal

• Subcutaneous

Palliative Care in Oncology Market, By End User

• Hospitals

• Hospice Care Centers

• Home Care Settings

• Cancer Specialty Clinics

Palliative Care in Oncology Market, By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Palliative Care in Oncology Market, By Region

• United States

• Canada

• Germany

• United Kingdom

• France

• Italy

• Spain

• China

• Japan

• India

• South Korea

• Australia

• Brazil

• Mexico

• Saudi Arabia

• South Africa

Palliative Care in Oncology Market Key Players

• Pfizer Inc.

• Teva Pharmaceutical Industries Ltd.

• Novartis AG

• Merck & Co., Inc.

• GlaxoSmithKline plc

• Mylan N.V. (Viatris)

• Hikma Pharmaceuticals PLC

• Johnson & Johnson

• Sanofi

• Baxter International Inc.